Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Travel and Lodging | $4,007 | 14 | 53.5% |
| Food and Beverage | $3,488 | 46 | 46.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ACELL, INC. | $1,850 | 14 | $0 (2019) |
| DAVOL INC. | $1,841 | 9 | $0 (2018) |
| TELA Bio, Inc. | $1,205 | 11 | $0 (2019) |
| Intuitive Surgical, Inc. | $770.76 | 3 | $0 (2019) |
| Teva Pharmaceuticals USA, Inc. | $514.01 | 5 | $0 (2024) |
| Gilead Sciences, Inc. | $479.57 | 5 | $0 (2022) |
| Acera Surgical, Inc. | $168.78 | 3 | $0 (2024) |
| Amarin Pharma Inc. | $123.24 | 1 | $0 (2019) |
| Global Blood Therapeutics, Inc. | $121.83 | 1 | $0 (2022) |
| Novo Nordisk Inc | $121.35 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $351.53 | 4 | Acera Surgical, Inc. ($143.82) |
| 2023 | $132.06 | 2 | Teva Pharmaceuticals USA, Inc. ($107.10) |
| 2022 | $313.58 | 3 | Global Blood Therapeutics, Inc. ($121.83) |
| 2021 | $198.71 | 2 | Teva Pharmaceuticals USA, Inc. ($198.71) |
| 2019 | $1,308 | 12 | ACELL, INC. ($977.59) |
| 2018 | $2,785 | 13 | DAVOL INC. ($1,546) |
| 2017 | $2,406 | 24 | TELA Bio, Inc. ($1,034) |
All Payment Transactions
60 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/20/2024 | Acera Surgical, Inc. | Restrata Wound Matrix (Device) | Food and Beverage | In-kind items and services | $121.92 | General |
| Category: Wound Care | ||||||
| 09/25/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $121.35 | General |
| Category: Obesity | ||||||
| 04/24/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $86.36 | General |
| Category: Central Nervous System | ||||||
| 03/13/2024 | Acera Surgical, Inc. | Restrata Wound Matrix (Device) | Food and Beverage | In-kind items and services | $21.90 | General |
| Category: Wound Care | ||||||
| 10/03/2023 | Acera Surgical, Inc. | Restrata Wound Matrix (Device) | Food and Beverage | In-kind items and services | $24.96 | General |
| Category: Wound Care | ||||||
| 09/27/2023 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $107.10 | General |
| Category: Neurology | ||||||
| 09/28/2022 | Global Blood Therapeutics, Inc. | OXBRYTA (Drug) | Food and Beverage | In-kind items and services | $121.83 | General |
| Category: Sickle Cell Disease | ||||||
| 06/23/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $97.02 | General |
| Category: Cardio-renal | ||||||
| 04/27/2022 | Gilead Sciences, Inc. | Descovy (Drug) | Food and Beverage | In-kind items and services | $94.73 | General |
| Category: HIV | ||||||
| 11/17/2021 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $69.96 | General |
| Category: Central Nervous System | ||||||
| 09/29/2021 | Teva Pharmaceuticals USA, Inc. | AJOVY (Biological) | Food and Beverage | In-kind items and services | $128.75 | General |
| Category: Central Nervous System | ||||||
| 11/30/2019 | ACELL, INC. | — | Food and Beverage | Cash or cash equivalent | $34.30 | General |
| 08/28/2019 | Gilead Sciences, Inc. | Truvada (Drug) | Food and Beverage | In-kind items and services | $91.75 | General |
| Category: HIV | ||||||
| 08/15/2019 | Intuitive Surgical, Inc. | Da Vinci Surgical System (Device) | Food and Beverage | In-kind items and services | $17.85 | General |
| Category: SURGERY | ||||||
| 07/30/2019 | Intuitive Surgical, Inc. | Da Vinci Surgical System (Device) | Food and Beverage | In-kind items and services | $33.24 | General |
| Category: SURGERY | ||||||
| 05/22/2019 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $123.24 | General |
| Category: Hypertriglyceridemia | ||||||
| 02/13/2019 | TELA Bio, Inc. | Ovitex (Device) | Food and Beverage | In-kind items and services | $63.99 | General |
| Category: Surgical Mesh | ||||||
| 01/26/2019 | ACELL, INC. | — | Food and Beverage | Cash or cash equivalent | $41.53 | General |
| 01/26/2019 | ACELL, INC. | — | Travel and Lodging | Cash or cash equivalent | $30.47 | General |
| 01/25/2019 | ACELL, INC. | — | Travel and Lodging | Cash or cash equivalent | $431.60 | General |
| 01/25/2019 | ACELL, INC. | — | Travel and Lodging | Cash or cash equivalent | $261.42 | General |
| 01/25/2019 | ACELL, INC. | — | Food and Beverage | Cash or cash equivalent | $113.97 | General |
| 01/25/2019 | ACELL, INC. | — | Food and Beverage | Cash or cash equivalent | $64.30 | General |
| 11/24/2018 | TELA Bio, Inc. | Ovitex (Device) | Food and Beverage | In-kind items and services | $20.87 | General |
| Category: Surgical Mesh | ||||||
| 11/07/2018 | TELA Bio, Inc. | Ovitex (Device) | Food and Beverage | In-kind items and services | $85.64 | General |
| Category: Surgical Mesh | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 114 | 124 | $36,240 | $15,302 |
| 2022 | 5 | 143 | 153 | $58,925 | $18,983 |
| 2021 | 9 | 248 | 342 | $107,280 | $32,830 |
| 2020 | 7 | 223 | 284 | $95,445 | $30,086 |
All Medicare Procedures & Services
25 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 29 | 29 | $11,890 | $5,001 | 42.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 40 | 45 | $9,450 | $3,804 | 40.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 21 | 26 | $6,500 | $3,367 | 51.8% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 24 | 24 | $8,400 | $3,130 | 37.3% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 37 | 37 | $15,170 | $6,121 | 40.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 52 | 60 | $12,600 | $5,487 | 43.5% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 24 | 24 | $8,400 | $3,753 | 44.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 18 | 19 | $4,750 | $2,292 | 48.3% |
| 43246 | Insertion of stomach tube using a flexible endoscope | Facility | 2022 | 12 | 13 | $18,005 | $1,329 | 7.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 53 | 67 | $13,730 | $6,274 | 45.7% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 33 | 37 | $12,950 | $5,798 | 44.8% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 33 | 33 | $12,430 | $5,604 | 45.1% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 32 | 86 | $15,480 | $5,090 | 32.9% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 29 | 31 | $8,370 | $3,485 | 41.6% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 20 | 34 | $7,140 | $2,890 | 40.5% |
| 43246 | Insertion of stomach tube using an endoscope | Facility | 2021 | 23 | 24 | $33,240 | $2,246 | 6.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 12 | 12 | $1,240 | $907.32 | 73.2% |
| 17250 | Application of chemical agent to excessive wound tissue | Facility | 2021 | 13 | 18 | $2,700 | $535.33 | 19.8% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 50 | 53 | $18,550 | $8,255 | 44.5% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Office | 2020 | 33 | 33 | $11,880 | $5,077 | 42.7% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 53 | 63 | $12,600 | $4,882 | 38.7% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 28 | 32 | $6,720 | $3,569 | 53.1% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 15 | 36 | $7,560 | $3,118 | 41.2% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 21 | 44 | $6,280 | $2,660 | 42.4% |
| 43246 | Insertion of stomach tube using an endoscope | Facility | 2020 | 23 | 23 | $31,855 | $2,526 | 7.9% |
About Dr. Lacesha Brintley, MD
Dr. Lacesha Brintley, MD is a Specialist healthcare provider based in Detroit, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/10/2006. The National Provider Identifier (NPI) number assigned to this provider is 1942278320.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Lacesha Brintley, MD has received a total of $7,495 in payments from pharmaceutical and medical device companies, with $351.53 received in 2024. These payments were reported across 60 transactions from 15 companies. The most common payment nature is "Travel and Lodging" ($4,007).
As a Medicare-enrolled provider, Brintley has provided services to 728 Medicare beneficiaries, totaling 903 services with total Medicare billing of $97,201. Data is available for 4 years (2020–2023), covering 25 distinct procedure/service records.
Practice Information
- Specialty Specialist
- Other Specialties Surgery
- Location Detroit, MI
- Active Since 03/10/2006
- Last Updated 08/13/2013
- Taxonomy Code 174400000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1942278320
Products in Payments
- Ovitex (Device) $1,205
- Da Vinci Surgical System (Device) $770.76
- DAV-Phasix (Device) $197.47
- Truvada (Drug) $189.62
- PHASIX (Device) $184.74
- Restrata Wound Matrix (Device) $168.78
- AJOVY (Biological) $128.75
- Vascepa (Drug) $123.24
- AJOVY (Drug) $121.84
- OXBRYTA (Drug) $121.83
- Wegovy (Drug) $121.35
- UZEDY (Drug) $107.10
- Epclusa (Drug) $97.61
- DAV-XenMatrix AB (Device) $97.17
- Kerendia (Drug) $97.02
- ALLODERM (Device) $94.92
- Descovy (Drug) $94.73
- Austedo XR (Drug) $86.36
- AUSTEDO (Drug) $69.96
- ORBERA (Device) $51.19
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in Detroit
Muwaffak Abdulhak, M.d, M.D
Specialist — Payments: $659,690
Dr. Kathleen Maksimowicz-Mckinnon, Do, DO
Specialist — Payments: $25,246
Monte Harvill, Md, MD
Specialist — Payments: $13,209
Brian Rill, M.d, M.D
Specialist — Payments: $6,817
Dr. Deniz Altinok, Md, MD
Specialist — Payments: $1,411
Ashraf Mohamed, M.d, M.D
Specialist — Payments: $1,116